| Agriculture Health Study (NCT00352924) | National Cancer Institute (NCI) | 1993-04-30 |
| In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients (NCT00001336) | National Cancer Institute (NCI) | 1993-04-01 |
| SWOG-9245 Collecting and Storing Tissue Samples From Patients With Relapsed or Recurrent Non-Hodgkin Lymphoma After Treatment on a Southwest Oncology Group Clinical Trial (NCT00898872) | SWOG Cancer Research Network | 1993-03-01 |
| Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma (NCT00002521) | Temple University | 1993-02-01 |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT00002522) | Temple University | 1993-02-01 |
| Phase I Study of Intrathecal Topotecan (NCT00001333) | National Cancer Institute (NCI) | 1993-02-01 |
| New York Blood Center National Cord Blood Program (NCT00212407) | New York Blood Center | 1993-02-01 |
| High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NCT00003578) | Lymphoma Trials Office | 1993-01-01 |
| Melphalan in Patients With Neoplastic Meningitis (NCT00002750) | Duke University | 1992-12-01 |
| Combination Chemotherapy in Treating Older Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma (NCT00002576) | Cancer Research Campaign Clinical Trials Centre | 1992-11-01 |
| Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma (NCT00018954) | National Institutes of Health Clinical Center (CC) | 1992-10-01 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer (NCT00002515) | Memorial Sloan Kettering Cancer Center | 1992-10-01 |
| Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma (NCT00002501) | Alliance for Clinical Trials in Oncology | 1992-10-01 |
| SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease (NCT00002495) | SWOG Cancer Research Network | 1992-09-01 |
| A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833 (NCT00001302) | National Cancer Institute (NCI) | 1992-09-01 |
| Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer (NCT00002504) | Hoag Memorial Hospital Presbyterian | 1992-08-01 |
| Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome (NCT00002502) | Memorial Sloan Kettering Cancer Center | 1992-07-01 |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia (NCT00002494) | Alliance for Clinical Trials in Oncology | 1992-05-01 |
| Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma (NCT00002510) | Temple University | 1992-04-01 |
| Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer (NCT00002485) | Children's Oncology Group | 1992-02-01 |
| Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma (NCT00574626) | University of Nebraska | 1991-12-12 |
| High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors (NCT00060255) | Roswell Park Cancer Institute | 1991-12-01 |
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination Chemotherapy (NCT00002488) | Ottawa Regional Cancer Centre | 1991-12-01 |
| Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome (NCT00002479) | Northwestern University | 1991-10-01 |
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma (NCT00001270) | National Cancer Institute (NCI) | 1991-06-01 |
| Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer (NCT00002520) | Eastern Cooperative Oncology Group | 1990-12-07 |
| Chemotherapy Plus Radiation Therapy and Biological Therapy in Treating Patients With Hematologic Cancer (NCT00002553) | Fred Hutchinson Cancer Center | 1990-08-01 |
| Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00002481) | St. Luke's Medical Center | 1990-03-01 |
| Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma (NCT00002471) | Memorial Sloan Kettering Cancer Center | 1990-02-01 |
| Phase I Study of Intrathecal Mafosfamide (NCT00001251) | National Cancer Institute (NCI) | 1989-11-01 |
| RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease (NCT00002462) | European Organisation for Research and Treatment of Cancer - EORTC | 1989-09-01 |
| Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma (NCT00002715) | Stanford University | 1989-04-01 |
| SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma (NCT00900484) | SWOG Cancer Research Network | 1989-02-01 |
| Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma (NCT00002461) | Montefiore Medical Center | 1988-04-01 |
| Bone Marrow Grafting for Leukemia and Lymphoma (NCT00186147) | Stanford University | 1988-03-01 |
| Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation (NCT00002456) | Fred Hutchinson Cancer Center | 1986-05-01 |
| Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer (NCT00093678) | Eastern Cooperative Oncology Group | |
| Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NCT00265928) | University of Virginia | |
| BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00024115) | National Cancer Institute (NCI) | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00004114) | Jonsson Comprehensive Cancer Center | |
| Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell Lymphoma (NCT01386398) | European Organisation for Research and Treatment of Cancer - EORTC | |
| Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J (NCT00899015) | National Institutes of Health Clinical Center (CC) | |
| Expanded Access to Epcoritamab (NCT05692050) | AbbVie | |
| Combination Chemotherapy and/or Radiation Therapy in Treating Young Patients With Hodgkin's Lymphoma (NCT00417014) | Children's Cancer and Leukaemia Group | |
| Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma (NCT00086034) | Pharmacyclics LLC. | |
| Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00023816) | Jonsson Comprehensive Cancer Center | |
| Radiation Therapy or Combination Chemotherapy in Treating Young Patients With Hodgkin's Lymphoma (NCT00416377) | Children's Cancer and Leukaemia Group | |
| Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies (NCT01101412) | M.D. Anderson Cancer Center | |
| Managed Access Programs for CTL019, Tisagenlecleucel (NCT03601442) | Novartis Pharmaceuticals | |
| GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma (NCT00324831) | Favrille | |
| Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies (NCT00036023) | Amgen | |
| Dose-Dense Therapy in Aggressive Lymphoma (NCT00517894) | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Efficacy and Safety of Treatment With a Single Dose of 90Y-ibritumomab Tiuxetan in Patients With Low Tumor Burden Untreated or Indolent NHL (NCT00414089) | AHS Cancer Control Alberta | |
| Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) (NCT00320827) | Daiichi Sankyo | |